|
Age [years]
|
68.4 ± 9.74
|
67.8 ± 8.74
|
0.55
|
|
Age group [n; %]
| | | |
|
<59
|
32
|
25
|
0.59
|
|
60 -69
|
64
|
54
|
|
70-79
|
56
|
54
|
|
>80
|
23
|
13
|
|
Male gender [n; %]
|
129; 73.7%
|
113; 77.3%
|
0.44
|
|
Logistic EuroSCORE [%, 95% CI]
|
16.0 (13.4 to 18.2)
|
12.8 (10.9 to 14.6)
|
0.07
|
|
Ejection fraction [%]
|
50 (40; 64)
|
56 (45; 70)
|
0.001*
|
|
Height [cm]
|
172 (165; 176)
|
172 (166; 176)
|
0.65
|
|
Weight [kg]
|
82 (73; 93)
|
80 (70; 90)
|
0.11
|
|
Atrial fibrillation, preoperative [n; %]
|
9; 5.1%
|
6; 4.1%
|
0.66
|
|
COPD, preoperative [n; %]
|
17; 9.7%
|
9; 6.1%
|
0.24
|
|
Inhalative β2-Mimetic use [n; %]
|
5; 2.9%
|
4; 2.7%
|
0.94
|
|
Myocardial infarction preoperative [n; %]
|
140; 80%
|
116; 79.4%
|
0.90
|
|
Troponin I preoperative [ng/mL)A
|
5.1 (1.0 to 21)
|
3.8 (0.4 to 0.7)
|
0.15
|
|
Insulin-dependent diabetes [n; %]
|
15; 8.6%
|
11; 7.6%
|
0.73
|
|
Non insulin-dpendent diabetes [n; %]
|
26; 14.8%
|
21; 14.3%
|
1.0
|
|
Diabetic nephropathy [n;%]
|
9, 5.1%
|
5; 3.4%
|
0.45
|
|
Serum creatinine, preoperative [mg ×dL-1]
|
1.0 (0.8; 1.3)
|
0.9 (0.8; 1.2)
|
0.05*
|
|
Estimated GFR < 60 mL × min-1 × 1.73 m-2 [n; %]
|
63; 36%
|
32; 22%
|
0.006
|
|
No of grafts [n]
|
2.95 ± 0.88
|
2.7 ± 0.80
|
0.006*
|
|
LIMA use [n; %]
|
126; 72%
|
121; 83%
|
0.02*
|
|
Bypass time [min]
|
96 (69; 119)
|
74 (54; 93)
|
< 0.0001*
|
|
Aortic cross clamp time [min]
|
47 (34; 61)
|
37 (27; 50)
|
0.0002*
|
